Avita Medical is acquiring a California manufacturing facility where the company produces its cell-harvesting device that can regenerate skin to help treat…
Precision Therapeutics and Helomics have agreed to fully merge and cement their already close ties, pending approval from the stockholders of both companies.…
AbbVie has dumped one of Galapagos’ cystic fibrosis regimens after getting a look at underwhelming clinical data on a component of the triple combination. The…
Four months after Voyager Therapeutics’ chief and founder Steven Paul, M.D., said he would step down to become an “executive science adviser,” the neurological…
Duke University's poliovirus-based glioblastoma treatment burst on the scene in 2015, thanks to the CBS show "60 Minutes." At the time, only a few patients had…
AstraZeneca is partnering with nearby Cambridge University and Dutch firm Lumicks to launch a new drug discovery hub focused on single-molecule analysis—as well…
> Erytech stopped developing eryaspase in acute lymphoblastic leukemia (ALL), wiping out a near-term commercial opportunity. The French biotech filed for…
Following the sudden resignation of Vipin Garg, its president and CEO, Neos Therapeutics has poached AgeneBio chief executive Jerry McLaughlin to fill the top…